Huadong Medicine Company Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Huadong Medicine Company Limited with three other
companies in this sector in China:
China National Accord Medicines Corporation Limited
sales of 25.99 billion Chinese Renmimbi [US$3.79 billion]
of which 93%
was Pharmaceutical Sales),
Yunnan Baiyao Group Co., Ltd.
(20.74 billion Chinese Renmimbi [US$3.02 billion]
of which 56%
was Comodities Trading), and
China Medicine Health Industry Co Ltd
(20.56 billion Chinese Renmimbi [US$3.00 billion]
of which 48%
was Pharmaceutical Business-pure/simple vend).
Huadong Medicine Company Limited reported sales of 21.73 billion Chinese Renmimbi (US$3.17 billion)
December of 2015.
increase of 14.7%
versus 2014, when the company's sales were 18.94 billion Chinese Renmimbi.
Sales at Huadong Medicine Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 142%).